Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.86 USD | +3.52% | +1.55% | +12.10% |
May. 10 | Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating | MT |
May. 09 | Transcript : Haemonetics Corporation, Q4 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 | 1.31B | Sales 2025 * | 1.38B | Capitalization | 4.87B |
---|---|---|---|---|---|
Net income 2024 | 118M | Net income 2025 * | 158M | EV / Sales 2024 | 3.29 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.54 x |
P/E ratio 2024 |
37
x | P/E ratio 2025 * |
29
x | Employees | 3,034 |
Yield 2024 * |
2.09% | Yield 2025 * |
2.09% | Free-Float | 99.24% |
Latest transcript on Haemonetics Corporation
1 day | +3.52% | ||
1 week | +1.55% | ||
Current month | +4.25% | ||
1 month | +11.27% | ||
3 months | +29.19% | ||
6 months | +11.31% | ||
Current year | +12.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 16-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 53 | 22-04-10 |
Jan Hartmann
CTO | Chief Tech/Sci/R&D Officer | - | 06-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Abernathy
BRD | Director/Board Member | 69 | 17-10-17 |
Director/Board Member | 69 | 14-07-22 | |
Ellen Zane
CHM | Chairman | 72 | 18-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.28% | 0 M€ | +3.60% | ||
0.14% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 95.86 | +3.52% | 445,064 |
24-05-09 | 92.6 | -0.70% | 887,636 |
24-05-08 | 93.25 | -2.05% | 911,094 |
24-05-07 | 95.2 | -0.19% | 768,803 |
24-05-06 | 95.38 | +1.04% | 388,144 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.10% | 4.7B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- HAE Stock